Abstract:Colon cancer is a digestive tract tumor with one of the highest frequencies worldwide, and with a high fatality rate. The present study aimed to investigate the expression and regulation of inflammatory factors in tumor tissues, monocytes and blood samples in patients with colon cancer (n=46) following treatment with neoadjuvant chemotherapy combined with tetrandrine. All patients underwent tumor resection after neoadjuvant chemotherapy. In the experimental group, 20 cases took tetrandrine during chemotherapy, while in the control group, 26 cases underwent chemotherapy without tetrandrine. Reverse transcription-quantitative PCR and western blotting were performed to detect the mRNA and protein expression levels of TNF-α. ELISA was used to detect the cytokine/chemokine expression levels [IL-15, IL-1β and IL-6, as well as chemokine ligand (CCL)2, CCL5, CCL20, chemokine (C-X-C motif) ligand CXCL1, CXCL2, CXCL3, CXCL5 and CXCL10 in the culture supernatant of colon cancer tissue]. Human blood mononuclear cells were cultured, and cytokine release was determined by ELISA. Cell proliferation ability was assessed using the MTT assay. Compared with the control group, the mRNA and protein expression levels of tumor necrosis factor-α (TNF-α) were downregulated in tumor tissues and serum and the serum levels of IL-15, IL-1β and IL-6 were relatively low in the experimental group. The expression levels of CCL5, CXCL2 and CXCL10 in the supernatant of cancer tissue culture were relatively low, compared with the conditioned medium prepared from tumor tissues of patients not receiving tetrandrine. When the cultured blood mononuclear cells were stimulated by the tissue culture supernatant from the experimental group, less IL-15, IL-1β and IL-6 were released, compared with the medium of tumor tissues of patients not taking tetrandrine. Following stimulation with the tissue culture supernatant from the experimental group, the proliferation ability of HCT116 colon cancer cells significantly declined. During chemotherapy of patients with colon cancer, tetrandrine may inhibit the expression of TNF-α in cancer tissues and blood, reduce the release of inflammatory factors and chemokines and decrease cancer cell proliferation. These findings provide a theoretical basis for the treatment of colon cancer in the clinic.

Qualitative and quantitative study on the apoptosis of cervical cancer cells treated by tetrandrine

Tetrandrine induces apoptosis and triggers a caspase cascade in U2-OS and MG-63 cells through the intrinsic and extrinsic pathways.

Effect of RNA Interference Targeting Egr-1 Inhibite Tetrandrine-Induced Autophagy and Apoptosis of Pancreatic PaTu8988 Cells in Vitro

Study on the efficacy of Tetrandrine in inducing the apoptosis of neuroblastoma cells

The Effects of Tetrandrine on Proliferation and Apoptosis of Hunman Ovarian Cancer Cell Line A2780

Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines

Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells.

Growth inhibition and apoptosis induction of tetrandrine in human thyroid cancer cells(B-CPAP)

Tetrandrine Induces Apoptosis in Gallbladder Carcinoma in Vitro.

Anti-proliferative and Apoptotic Effects of S1, a Tetrandrine Derivative, in Human Gastric Cancer BGC-823 Cells

Antineoplastic effect of tetrandrine on primary cancer cells isolated from ascites

Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids.

Effects of Tetrandrine on apoptosis and cell cycle of human choriocarcinoma BeWo cells

Study on the mechanism of oral administration of tetrandrine during neoadjuvant chemotherapy for colon cancer

Study on the resveratrol induced apoptosis in hunman cervical cancer cell line HeLa

The effect of quercetin on cervical cancer cells as determined by inducing tumor endoplasmic reticulum stress and apoptosis and its mechanism of action

Effect of Tetrandrine on Fibroblast's Apoptosis of Scar

Tetrandrine Induces Apoptosis Via Caspase-8, -9, and -3 and Poly (ADP Ribose) Polymerase Dependent Pathways and Autophagy Through Beclin-1/ LC3-I, II Signaling Pathways in Human Oral Cancer HSC-3 Cells.

Tetrandrine Induces Programmed Cell Death in Human Oral Cancer CAL 27 Cells Through the Reactive Oxygen Species Production and Caspase-Dependent Pathways and Associated with Beclin-1-induced Cell Autophagy.

Tetrandrine Enhances Radiosensitization in Human Hepatocellular Carcinoma Cell Lines

Antagonistic effect of tetrandrine on multidrug resistance of breast cancer cells and the antioxidant mechanism